- SYRS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Syros Pharmaceuticals (SYRS) S-3Shelf registration
Filed: 20 Jul 17, 12:00am
Exhibit 12.1
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(dollars in thousands)
|
| Three Months |
| Year Ended December 31, |
| |||||||||||
|
| 2017 |
| 2016 |
| 2015 |
| 2014 |
| 2013 |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
| |||||
Interest expense on indebtedness |
| $ | 3 |
| $ | 19 |
| $ | 18 |
| $ | — |
| $ | 33 |
|
Interest expense on portion of rent expense representative of interest |
| 301 |
| 1,187 |
| 364 |
| 241 |
| 244 |
| |||||
Total fixed charges |
| $ | 304 |
| $ | 1,206 |
| $ | 382 |
| $ | 241 |
| $ | 277 |
|
|
|
|
|
|
|
|
|
|
|
|
| |||||
Net loss |
| $ | (11,515 | ) | $ | (47,743 | ) | $ | (29,818 | ) | $ | (13,431 | ) | $ | (8,665 | ) |
Fixed charges per above |
| 304 |
| 1,206 |
| 382 |
| 241 |
| 277 |
| |||||
Total earnings (loss) |
| $ | (11,211 | ) | $ | (46,537 | ) | $ | (29,436 | ) | $ | (13,190 | ) | $ | (8,388 | ) |
|
|
|
|
|
|
|
|
|
|
|
| |||||
Ratio of earnings to fixed charges |
| N/A |
| N/A |
| N/A |
| N/A |
| N/A |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Deficiency of earnings available to cover fixed charges |
| $ | (11,515 | ) | $ | (47,743 | ) | $ | (29,818 | ) | $ | (13,431 | ) | $ | (8,665 | ) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.